Contraindicated (one)pentobarbital decreases levels of panobinostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Potent CYP3A4 inducers can minimize panobinostat levels by ~70% and bring about treatment failure. By clicking send, you accept you have authorization to e-mail the recipient using this type of info. H